ScholarIQanswers from OpenAlex
Yong In University
InstitutionResearch output, impact & collaborations
Yong In University is a institution indexed in ScholarIQ from OpenAlex.
What is known about Yong In University?
ScholarIQrecord summary
Yong In University is a research organisation in Seoul, KR. OpenAlex records 6,320 works and 174,741 citations for it. 1,332 researchers list it as their most recent affiliation.
How many works does Yong In University have?
ScholarIQindexed works
Yong In University has 6,320 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yong In University have?
ScholarIQcitation count
Yong In University has 174,741 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Yong In University?
ScholarIQresearcher count
Yong In University has 1,332 researchers in the ScholarIQ index.
What is the average h-index at Yong In University?
ScholarIQavg h-index
Yong In University has an average h-index of 72.3 in OpenAlex.
What is the ROR of Yong In University?
ScholarIQror
The ROR for Yong In University is on the source record.
What is the OpenAlex record for Yong In University?
ScholarIQopenalex
The OpenAlex for Yong In University is on the source record.
What is the Wikidata of Yong In University?
ScholarIQwikidata
The Wikidata for Yong In University is on the source record.
Who are the most-cited researchers behind Yong In University?
ScholarIQtop researchers by citations
What are the most-cited papers on Yong In University?
ScholarIQmost cited works
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
Nayoung Kim, Hong Kwan Kim, Kyungjong Lee, Yourae Hong, Jong Ho Cho, Jung Won Choi, Jung-Il Lee, Yeon‐Lim Suh, Bo Mi Ku, Hye Hyeon Eum, Soyean Choi, Yoon‐La Choi, Je‐Gun Joung, Woong‐Yang Park, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn, Hae‐Ock Lee
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
Takashi Kojima, Manish A. Shah, Kei Muro, Éric François, Antoine Adenis, Chih‐Hung Hsu, Toshihiko Doi, Toshikazu Moriwaki, Sung‐Bae Kim, Se‐Hoon Lee, Jaafar Bennouna, Ken Kato, Lin Shen, Peter C. Enzinger, Shukui Qin, Paula Ferreira, Jia Chen, Gustavo Girotto, Christelle de la Fouchardière, Hélène Senellart, Raed Moh’d Taiseer Al-Rajabi, Florian Lordick, Ruixue Wang, Shailaja Suryawanshi, Pooja Bhagia, Soonmo Peter Kang, Jean‐Philippe Metges, on behalf of the KEYNOTE-181 Investigators
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Heather A. Wakelee, Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi, Se‐Hoon Lee, Shugeng Gao, Ke‐Neng Chen, Christophe Dooms, Margarita Majem, E. Eigendorff, Gastón Lucas Martinengo, Olivier Bylicki, Delvys Rodríguez‐Abreu, Jamie E. Chaft, Silvia Novello, Jing Yang, Steven M. Keller, Ayman Samkari, Jonathan Spicer
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Kevin Litchfield, James L. Reading, Clare Puttick, Krupa Thakkar, Chris Abbosh, Robert B. Bentham, Thomas B.K. Watkins, Rachel Rosenthal, Dhruva Biswas, Andrew Rowan, Emilia L. Lim, Maise Al Bakir, Virginia Turati, José Afonso Guerra‐Assunção, Lucía Conde, Andrew J.S. Furness, Sunil Kumar Saini, Sine Reker Hadrup, Javier Herrero, Se‐Hoon Lee, Peter Van Loo, Tariq Enver, James Larkin, Matthew D. Hellmann, Samra Turajlic, Sergio A. Quezada, Nicholas McGranahan, Charles Swanton
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Laura Q.M. Chow, Robert I. Haddad, Shilpa Gupta, Amit Mahipal, Ranee Mehra, Makoto Tahara, Raanan Berger, Joseph P. Eder, Barbara Burtness, Se‐Hoon Lee, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Jared Weiss, Ravit Geva, Chia‐Chi Lin, Hyun Cheol Chung, Amy Meister, Marisa Dolled‐Filhart, Kumudu Pathiraja, Jonathan D. Cheng, Tanguy Y. Seiwert
How much of the research on Yong In University is open access?
ScholarIQopen access share
75%OPEN ACCESS